An investigation of hormone and lipid associations after weight loss in women

Journal of the American College of Nutrition

Volumn 26, Issue 3, 2007, Pages 250-258

  Santosa, Sylvia ^a   Demonty, Isabelle ^a   Lichtenstein, Alice H ^c   Cianflone, Katherine ^b   Jones, Peter J H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Adipocyte hormones; Cholesterol; Ghrelin; Weight loss; Women

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; CHOLESTEROL; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FEMALE; HORMONE DETERMINATION; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; METABOLISM; RISK FACTOR; RISK REDUCTION; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIET, REDUCING; ENERGY METABOLISM; EXERCISE; FEMALE; HUMANS; HYPERLIPIDEMIAS; LEPTIN; LIPIDS; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WEIGHT LOSS;

EID: 34547234162     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2007.10719608     Document Type: Article

References (35)

1. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102:2284–2299, 2000.
2. American Diabetes Association: Position Statement: Nutrition principles and recommendations in diabetes. Diabetes Care 27: S36–S46, 2004.
3. Wing RR, Jeffery RW: Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord 19:67–73, 1995.
4. Dattilo AM, Kris-Etherton PM: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56:320–328, 1992.
5. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155–1161, 1995.
6. Wu JT, Kral JG: Ghrelin integrative neuroendocrine peptide in health and disease. Ann Surg 239:464–467, 2004.
7. Ostlund RE Jr, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81:3909–3913, 1996.
8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83, 1999.
9. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935, 2001.
10. Spranger J, Kroke, A, Mohlig M, Bermann MM, Ristow M, Boeing H, Pfeiffer AFH: Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226–228, 2003.
11. Diez JJ, Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300, 2003.
12. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730–1737, 2004.
13. Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rossner S, Saris W, Van Gaal L, James W, Goulder M For The STORM Study Group: Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord 25:496–501, 2001.
14. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G: Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50:795–800, 2001.
15. McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chem Acta 166:1–8, 1987.
16. Wang TY, Haddad M, Wang TS: Low triglyceride levels affect calculation of low-density lipoprotein cholesterol values. Arch Pathol Lab Med 125:404–405, 2001.
17. Rafai N, Iannotti RN, DeAngelis K, Law T: Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chem 44:1242–1250, 1998.
18. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ: Reference intervals for plasma apolipoprotein A1 as determined with a commercially available immunoturbidometric assay: Results from the Framingham Offspring Study. Clin Chem 42:507–514, 1996.
19. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ: Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42:515–523, 1996.
20. Morgan CR, Lazarow A: Immunoassay of insulin: Two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Proc Soc Exp Med. 12:115–126, 1962.
21. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM: Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89:2697–2703, 2004.
22. Ryan AS, Nicklas BJ, Berman DM, Elahi D: Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 27:1066–1071, 2003.
23. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799–1804, 2003.
24. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO: Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol 56:203–206, 2002.
25. Zahorska-Markiewicz B, Mizia-Stec K, Olszanecka-Glinianowicz M, Janowska J: Effect of weight reduction on serum ghrelin and TNFα concentrations in obese women. Eur J Inten Med 15:172–175, 2004.
26. Kazumi T, Kawaguchi A, Hirano T, Yoshino G: Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 53:589–593, 2004.
27. Baratta R, Amato S, Degano C, Farina MG, Patane G, Vigneri R, Frittatta L: Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665–2671, 2004.
28. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocytederived protein. Diabetes 51:2734–2741, 2002.
29. Svendsen OL, Hassager C, Christiansen C: Effect of an energyrestrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med 95:131–140, 1993.
30. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E: Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 88:168–173, 1991.
31. Hoag S, Marshall JA, Jones RH, Hamman RF: High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: the San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 19:175–180, 1995.
32. Di Buono M, Hannah JS, Katzel LI, Jones PJ: Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr 129:1545–1548, 1999.
33. Raeini-Sarjaz M, Vanstone CA, Papamandjaris AA, Wykes LJ, Jones PJ: Comparison of the effect of dietary fat restriction with that of energy restriction on human lipid metabolism. Am J Clin Nutr 73:262–267, 2001.
34. Dietschy JM, Turley SD, Spady DK: Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 34:1637–1659, 1993.
35. Miettinen TA, Gylling H: Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153:241–248, 2000.